These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 22363864)

  • 1. Cell proliferation in cutaneous malignant melanoma: relationship with neoplastic progression.
    Piérard GE
    ISRN Dermatol; 2012; 2012():828146. PubMed ID: 22363864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular pathways supporting the proliferation staging of malignant melanoma (review).
    Quatresooz P; Pierard GE; Pierard-Franchimont C;
    Int J Mol Med; 2009 Sep; 24(3):295-301. PubMed ID: 19639220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. lncRNA TINCR attenuates the proliferation and invasion, and enhances the apoptosis of cutaneous malignant melanoma cells by regulating the miR‑424‑5p/LATS1 axis.
    Han X; Jia Y; Chen X; Sun C; Sun J
    Oncol Rep; 2021 Nov; 46(5):. PubMed ID: 34542165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LINC01296 promotes proliferation of cutaneous malignant melanoma by regulating miR-324-3p/MAPK1 axis.
    Wang K; Luo Q; Zhang Y; Xie X; Cheng W; Yao Q; Chen Y; Ren H; Li J; Pan Z
    Aging (Albany NY); 2022 Dec; 15(8):2877-2890. PubMed ID: 36462499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dormancy of growth-stunted malignant melanoma: sustainable and smoldering patterns.
    Piérard-Franchimont C; Hermanns-Lê T; Delvenne P; Piérard GE
    Oncol Rev; 2014 Sep; 8(2):252. PubMed ID: 25992239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of melanocortin 1 receptor in cutaneous malignant melanoma: along the mitogen-activated protein kinase pathway.
    Steck MB
    Biol Res Nurs; 2014 Oct; 16(4):421-8. PubMed ID: 24443365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-330-5p regulates tyrosinase and PDIA3 expression and suppresses cell proliferation and invasion in cutaneous malignant melanoma.
    Su BB; Zhou SW; Gan CB; Zhang XN
    J Surg Res; 2016 Jun; 203(2):434-40. PubMed ID: 27363653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GSTO1 regards as a meritorious regulator in cutaneous malignant melanoma cells.
    Wang LK; Yue HL; Peng XJ; Zhang SJ
    Mol Cell Probes; 2019 Dec; 48():101449. PubMed ID: 31525447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AXL and CAV-1 play a role for MTH1 inhibitor TH1579 sensitivity in cutaneous malignant melanoma.
    Das I; Gad H; Bräutigam L; Pudelko L; Tuominen R; Höiom V; Almlöf I; Rajagopal V; Hansson J; Helleday T; Egyházi Brage S; Warpman Berglund U
    Cell Death Differ; 2020 Jul; 27(7):2081-2098. PubMed ID: 31919461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profiling of primary cutaneous melanoma.
    Winnepenninckx V; Van den Oord JJ
    Verh K Acad Geneeskd Belg; 2007; 69(1):23-45. PubMed ID: 17427873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA analysis of tape strips to rule out melanoma in lesions clinically assessed as cutaneous malignant melanoma: A diagnostic study.
    Heerfordt IM; Philipsen PA; Andersen JD; Langhans L; Schmidt G; Morling N; Wulf HC
    J Am Acad Dermatol; 2023 Sep; 89(3):537-543. PubMed ID: 37224970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sister chromatid exchange and proliferation pattern in stimulated lymphocytes of cutaneous malignant melanoma patients.
    Privitera E; Ghidoni A; Raimondi E; Rovini D; Illeni MT; Cascinelli N
    Cancer Genet Cytogenet; 1985 Feb; 15(1-2):37-45. PubMed ID: 3967218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of neutral endopeptidase and motility-related protein-1 in cutaneous malignant melanoma].
    Wu Y; Zhang XB; Liu HJ; Zheng LD; Li JW; Lin Y
    Zhonghua Bing Li Xue Za Zhi; 2007 Jul; 36(7):466-9. PubMed ID: 17845760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-186 inhibits cell proliferation and invasion in human cutaneous malignant melanoma.
    Su BB; Zhou SW; Gan CB; Zhang XN
    J Cancer Res Ther; 2018; 14(Supplement):S60-S64. PubMed ID: 29578151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and histologic features of level 2 cutaneous malignant melanoma associated with metastasis.
    Taran JM; Heenan PJ
    Cancer; 2001 May; 91(9):1822-5. PubMed ID: 11335909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Truncating mutations of TP53AIP1 gene predispose to cutaneous melanoma.
    Benfodda M; Gazal S; Descamps V; Basset-Seguin N; Deschamps L; Thomas L; Lebbe C; Saiag P; Zanetti R; Sacchetto L; Chiorino G; Scatolini M; Grandchamp B; Bensussan A; Soufir N
    Genes Chromosomes Cancer; 2018 Jun; 57(6):294-303. PubMed ID: 29359367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression analysis of ovostatin 2 reveals its involvement in proliferation, invasion and angiogenesis of cutaneous malignant melanoma.
    Huang YX; Qi J; Wang HS; Shao XB; Zeng XS; Li AM; Xu XL; Sun JF
    J Dermatol; 2013 Nov; 40(11):901-10. PubMed ID: 24112097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Alternative TrkAIII Splice Variant, a Targetable Oncogenic Participant in Human Cutaneous Malignant Melanoma.
    Cappabianca L; Zelli V; Pellegrini C; Sebastiano M; Maccarone R; Clementi M; Chiominto A; Ruggeri P; Cardelli L; Ruggieri M; Sbaffone M; Fargnoli MC; Guadagni S; Farina AR; Mackay AR
    Cells; 2023 Jan; 12(2):. PubMed ID: 36672171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-92a regulates the development of cutaneous malignant melanoma by mediating FOXP1.
    Sun HW; Yang GL; Wang SN; Zhang YJ; Ding JX; Zhang XN
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8991-8999. PubMed ID: 31696487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant melanoma and its stromal nonimmune microecosystem.
    Piérard GE; Piérard-Franchimont C; Delvenne P
    J Oncol; 2012; 2012():584219. PubMed ID: 22811710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.